| NDC Code | 71655-578-04 |
|---|
| Package Description | 4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) |
|---|
| Product NDC | 71655-578 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ebanga |
|---|
| Non-Proprietary Name | Ansuvimab |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20201221 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761172 |
|---|
| Manufacturer | Emergent Manufacturing Operations Baltimore, LLC |
|---|
| Substance Name | ANSUVIMAB |
|---|
| Strength | 400 |
|---|
| Strength Unit | mg/8mL |
|---|
| Pharmacy Classes | Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA], Zaire Ebolavirus Glycoprotein-directed Antibody [EPC] |
|---|